stent in the development ISR in our population subsets.
Methods:
Patients were selected from those who underwent routine coronary angiogram for further evaluation of their coronary status. Most of the patient population in this study had percutaneous coronary intervention (PCI) either with bare metal stent or drug eluting stent in the preceding 3-36 months. Eligible patients had a history of stable or unstable angina or documented / silent myocardial infarction. The target lesion for study was an in-stent coronary arterial lesion between 15 mm and 40 mm with 2.5-4.0 mm in diameter. No exclusion criteria adopted because of the small sample size.
Procedure: CAG was performed as per standard protocol. Individual discretion was applied as per operator's choice, depending on patient's problem. Details of the previous procedure were collected from patient's old papers. These included indication, stent detail, complication etc. Whenever possible, old angiogram was also reviewed and compared to the current cine angiogram. ISR was defined by visual / eyeball estimation by two experts. Edge re-stenosis was defined as greater than 50% narrowing in the 5mm immediate or distal to the treated region. ISR of significance was also defined as >50% was of lumen inside the stent. Data were presented as mean ± SD with percentage.
Results:
Our results show that, 12.5%(51) patient out of total 408 patients, has multiple stent in single coronary territory were included in this study. Average age was Male: 57; Female:61. Among the studied population 42 were Male and 98 were female. Table I. showing the profile and clinical data of studied population. Female are older than male (male 57.2 ± 12.4 vs female:61 ± 12.4) and obese as male(BMI in male: 26.0 ± 4.1 vs female 26.0 ± 4.1). Systolic BP were higher in male than female (Male: Female SBP: 136 ± 14.9 vs 126.0 ± 14.9; DBP: 78.5 ±7.5 vs 78.4 ±7.5). Average number of CAD risk factors was higher in male than female (2.83± 0.7: 2.5 ± 0.7). Average duration the development of ISR was 3.1 ± 2.4yrs Fig . 1 showing the coronary artery territory wise percentage distribution of stent used; it's patency and subsequent development of ISR. LAD and LCX has reduced ISR development. 
Discussion:
Previously, we for the first time published the stent patency and the development subsequent ISR in Bangladeshi patient population. 15 Since, we don't have any data in our patient perspective on the overlapping / multiple stents in a single vessel territory. Therefore, we have carried out this non-randomized prospective cohort to see which stent is better or have reduced ISR development.
With the advances of patient management, patients with Acute Myocardial Infarction (AMI) or Acute Coronary Syndrome (ACS), PCI by using bare metal stent (BMS) reduces the acute closure or late restenosis 30-50% compared with balloon angioplasty alone, has already established. [16] [17] With the property of site specific antiproliferating drug delivery system by drug eluting stent (DES) reduces the clinical and angiographic restenosis by <10% by inhibiting neointimal hyperplasia. [18] [19] Restenosis after angioplasty and stent implantation has been historically considered the most significant problem in coronary interventional treatment. 20 Neointimal hyperplasia has been identified as underlying mechanism of development of ISR. 9 The implantation of multiple/overlapping stents may be prompted by excessive target lesion length, incomplete lesion coverage and or endothelial injury requiring additional stents scaffolding beyond the margins of the initial stent deployed. 14 Furthermore, multiple overlapping stents may be required to repair extensive spiral coronary dissection. Stent strut overlap has been incriminated both as stimulus to neointimal hyperplasia and to late angiographic restenosis. [21] [22] [23] . Implantation of multiple stents presents technical challenges in delivery and alignment to insure adequate stent overlap and lesion coverage. Stent overlap is associated with neointimal proliferation and subsequent late lumen loss regardless of stent type. Deliberate stent overlap is a recognized option for the treatment of in-stent restenosis for both bare metal and drug eluting stent. 24 Maximal lumen narrowing occurs at the sites of DES overlap in majority of patient with increased drugs and polymer concentration. Theoretical concerns related to the use of overlapping drug-eluting stents include potential toxic effect of 'double' doses of a drug on the vascular wall which may result in positive remodeling, aneurysm formation and possible stent thrombosis. As well as aggravated restenosis as a consequence of increased implantation injury and delayed healing; potential adverse reaction to a polymer delivery system in terms of inflammation and thrombogenic effects may also increase with overlapping stent. 25, 26 However, the relative contribution of target lesion length, total stented segment and number of deployed stent per target lesion toward the occurrence of periprocedural MACE and or late angiographic stenosis is debatable. 7, 8, 28 Keriakes shown that 1 st generation Drug eluting stent (DES) Sirolimus-eluting stent is safe, effecious in reducing restenosis with no increase in the incidence of MI compare to BMS. 14 On the contrary, 2 nd generation Everolimus eluting stent (EES) compared with Paclitaxel eluting stent (PES) provided significant improvements in clinical safety and efficacy. 27 Possible explanation of 1 st generation is because of thick strut and high metal contents impair deliverability, increase stent mediated vascular injury, the 2 nd generation DES has thin strut cobalt chromium platform with less metal content easy to deliver with flexibility and less vascular injury.
In our present study we found that female are more obese and developed CAD in more advance age than male patients. Admission BP was higher in male either due to obesity or from noncompliance to their current medication. We also found that average number of CAD risk factors were higher in male than female, although male are having one more exclusive CAD risk factors as being smoker. Among the CAD risk factors dyslipidemia contributed an important role in the development of atherosclerotic CAD followed by HTN, DM and positive FH and smoking (all male patients). We found, Sirolimus-eluting stent has reduced ISR than other limus and Paclitaxel-eluting stent. LAD and LCX artery shows increase patency with reduced ISR development, whether RCA has less patency with increased ISR. Stent under sizing and or inappropriate inflation during deployment could be one of the possible reasons of increased ISR in RCA. In addition use of IVUS support, these issues could have been addressed. 
Conclusion:
Overlapping stents in a single coronary artery lesion carries a risk of restenosis. Several studies have shown the promising result of different DES. Among them, many has shown potential better outcome with reduced ISR in Sirolimus eluting stent and non-inferior results by 2 nd generation EES DES. It is difficult to conclude in this present prospective cohort which DES is better in our patient perspective. We need more data and multicenter registry in Bangladesh in addition to statistical significance. Because of the small number, we could not able to do the comparative study between BMS with DES or between 1 st and 2 nd generation DES. In this regards, our future plan is to enroll more patient and involver more center and to find out which DES is appropriate in reducing angiographic restenosis in overlapping segment if possible to do randomize comparative study.
Limitation: Most of our studied patients had their PCI done either with BMS or DES in other centers. We had to depend on the reports provided by the patients. Although they all included stent details, procedural details were missing. We eventually got only information about the type of stent used and few other details.
